NEW YORK, Nov. 10, 2016 – The Lung Cancer Research Foundation (LCRF™) held its signature gala, the Fourteenth Annual Strolling Supper, on Wednesday, November 9 at Gotham Hall in New York City. The event was hosted by Bill Ritter, Co-Anchor Eyewitness News at 6 & 11, and raised the highest amount ever, nearly $1.5 million, to benefit lung cancer research.
View the Lung Cancer Research Foundation's video Generations: Connecting for Impact
The Lung Cancer Research Foundation announced the awardees of its 2016 Scientific Grant Program at the Eleventh Annual Lung Cancer Awareness Luncheon, held on Monday, October 17, at The Pierre in New York City. In another record-breaking year, LCRF awarded $2.2 million in research grants to 15 researchers as part of the LCRF Scientific Grant Program, an annual program that funds projects across the spectrum of basic, clinical and translational lung cancer research.
The Lung Cancer Research Foundation (LCRF) and Uniting Against Lung Cancer (UALC) have elected to merge to amplify their impact on advancing lung cancer research.
The Lung Cancer Research Foundation welcomes submissions of grant requests for medical/scientific research projects covering all aspects of lung cancer research. Grant requests can include new project submissions, as well as requests for renewal of current funding.
As a post-doctoral fellow at the University of Texas’ MD Anderson Cancer Center, Dr. Warren L. Denning has had his fair share of opportunities to work with some of the world’s leading cancer researchers. Dr. Denning, a 2014 LCRF Grant awardee, also received the prestigious LCRF Scientific Merit Award. The award is given to the researcher who achieves the highest overall merit score as determined by the Lung Cancer Research Foundation (LCRF) Medical Advisory Board. Dr. Denning follows in the footsteps of colleague, Dr. Faye Johnson, the 2013 LCRF Scientific Merit Award winner.
Ms. Miles, a recipient of a 2014 LCRF Research Grant, is a current PhD student at Johns Hopkins University in Baltimore, MD. She is currently completing her program studies at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City, one of the most esteemed cancer centers in the world.
The Lung Cancer Research Foundation (LCRF) strongly supports the recent proposal issued by The Centers for Medicare and Medicaid Services to begin covering lung cancer screening tests for high risk patients.
LUNGevity Foundation today announced a partnership with the Lung Cancer Research Foundation and Melanoma Research Alliance to co-fund new innovative research on PD-1 inhibitor treatment options for both non-small cell lung cancer (NSCLC) and metastatic melanoma (MM) patients with brain metastases.
In November 2010, the National Lung Screening Trial (NLST) announced results which identified a 20% relative reduction in lung cancer mortality from screening for lung cancer with low-dose computed tomography (LDCT) compared to Chest radiograph. These results, from a large and well-designed randomized controlled trial (RCT), prompted professional societies to advocate the use of LDCT screening in high risk populations.
Knowledge about the genetic mutations that cause tumors is offering the first real promise of drugs that can control lung cancer.
ASCO President urges for increased budgets to dedicate to lung cancer research.
LCRF grant helps lung cancer research get one step closer to eliminating the disease.
The research from a study funded by LCRF in 2010 and 2011 was just published in the Journal of the National Cancer Institute. The study found that cells appearing normal may actually be harbingers of lung cancer. Join us in congratulating Humam Kadara, PHD on his work!